Boston Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Boston Partners’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Sell	75,838 -8,995	-11%	-$47.3K	﹤0.01%	733
2026 Q1	$355K	Buy	84,833 +18,057	+27%	+$86.9K	﹤0.01%	713
2025 Q4	$321K	Sell	66,776 -8,695	-12%	-$42.1K	﹤0.01%	721
2025 Q3	$382K	Sell	75,471 -109,238	-59%	-$483K	﹤0.01%	701
2025 Q2	$744K	Sell	184,709 -202,900	-52%	-$660K	﹤0.01%	620
2025 Q1	$1.06M	Buy	387,609 +181,819	+88%	+$652K	﹤0.01%	559
2024 Q4	$875K	Sell	205,790 -3,165	-2%	-$12K	﹤0.01%	581
2024 Q3	$614K	Buy	+208,955	New	+$665K	﹤0.01%	659

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners's SRTA Position: Q2 2026 in Review

Boston Partners reduced its Strata Critical Medical Inc (SRTA) stake by 11% in Q2 2026, selling an estimated $47.3K and leaving 75,838 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Boston Partners first reported a position in SRTA in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.06M in Q1 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Boston Partners held 75,838 shares of Strata Critical Medical Inc worth $400K as of Q2 2026.
Boston Partners sold 8,995 Strata Critical Medical Inc shares in Q2 2026, an estimated $47.3K.
Strata Critical Medical Inc made up ﹤0.01% of Boston Partners's portfolio in Q2 2026, its #733 holding.
Boston Partners first reported a position in Strata Critical Medical Inc in Q3 2024 and has held it in 8 quarters since.
Boston Partners's Strata Critical Medical Inc position peaked at $1.06M in Q1 2025.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.